Tyler Zeronda - Sep 30, 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Interim CFO
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol
VYNE
Transactions as of
Sep 30, 2021
Transactions value $
-$286
Form type
4
Date filed
10/1/2021, 05:12 PM
Previous filing
Sep 3, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$286 -206 -0.25% $1.39 83.3K Sep 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.